DaehanPharmaceutical operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares DaehanPharmaceutical with three other
companies in this sector in South Korea:
Kolon Life Science Incorporation
sales of 158.28 billion Korean Won [US$140.71 million]
of which 45%
was Environment Material),
(158.60 billion Korean Won [US$140.99 million]
of which 91%
was Medicine), and
Ctc Bio, Incorporation.
(123.15 billion Korean Won [US$109.48 million]
DaehanPharmaceutical reported sales of 139.44 billion Korean Won (US$123.96 million)
December of 2016.
increase of 12.2%
versus 2015, when the company's sales were 124.28 billion Korean Won.
Sales at DaehanPharmaceutical have increased during each of the previous five years
(and since 2011, sales have increased a total of 64%).